Cargando…
HPV Status as Prognostic Biomarker in Head and Neck Cancer—Which Method Fits the Best for Outcome Prediction?
SIMPLE SUMMARY: Head and neck cancer belongs to the six most common cancers worldwide, with the majority of cases being associated with chronic alcohol and/or tobacco consumption. Over the past years, a rising proportion of those cancer cases are rather caused by a mucosal infection with high-risk h...
Autores principales: | Kühn, Jan Philipp, Schmid, Wendelin, Körner, Sandrina, Bochen, Florian, Wemmert, Silke, Rimbach, Hugo, Smola, Sigrun, Radosa, Julia Caroline, Wagner, Mathias, Morris, Luc G.T., Bozzato, Victoria, Bozzato, Alessandro, Schick, Bernhard, Linxweiler, Maximilian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469433/ https://www.ncbi.nlm.nih.gov/pubmed/34572957 http://dx.doi.org/10.3390/cancers13184730 |
Ejemplares similares
-
Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis and clinical outcome of head and neck squamous cell carcinomas
por: Bochen, Florian, et al.
Publicado: (2016) -
Expression of SEC62 Oncogene in Benign, Malignant and Borderline Melanocytic Tumors—Unmasking the Wolf in Sheep’s Clothing?
por: Müller, Cornelia S. L., et al.
Publicado: (2021) -
Prognostic impact of intra- and peritumoral immune cell subpopulations in head and neck squamous cell carcinomas – comprehensive analysis of the TCGA-HNSC cohort and immunohistochemical validation on 101 patients
por: Knebel, Moritz, et al.
Publicado: (2023) -
Antagonizing Sec62 function in intracellular Ca(2+) homeostasis represents a novel therapeutic strategy for head and neck cancer
por: Körner, Sandrina, et al.
Publicado: (2022) -
Cytology-based Cancer Surgery of the Head and Neck (CyCaS-HN): a prospective, randomized, controlled clinical trial
por: Linxweiler, Maximilian, et al.
Publicado: (2022)